ArticleCureus2025
Giant Pheochromocytoma With Non-classical Symptoms: A Case Report to Expand Clinical Awareness.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pheochromocytomas are rare neuroendocrine tumors arising from chromaffin cells of the adrenal medulla or extra-adrenal paraganglia. Their clinical presentation varies widely among individuals and is primarily linked to the biological effects of excessive catecholamine secretion. We report an unusual case of pheochromocytoma presenting as epigastric heaviness. A 65-year-old male with a known history of type 2 diabetes mellitus, treated with metformin, and well-controlled hypertension managed with amlodipine, presented with a complaint of persistent epigastric heaviness in the absence of associated symptoms. Abdominal CT imaging revealed a large, locally infiltrative right adrenal mass measuring 92 x 82 x 80 mm. As part of the etiological work-up, serum potassium and urinary cortisol levels were within normal limits. The diagnosis of pheochromocytoma was established based on significantly elevated urinary metanephrines and normetanephrines, exceeding the normal values by 55-fold and 23-fold, respectively. The evaluation for multiple endocrine neoplasia syndromes was negative. Iodine-123 metaiodobenzylguanidine (¹²³I-MIBG) scintigraphy confirmed the presence of a hyperfixating adrenal mass, consistent with pheochromocytoma. Following adequate preoperative pharmacologic preparation, the patient underwent a right adrenalectomy. Histopathological analysis confirmed the diagnosis of pheochromocytoma. The postoperative course was uneventful. Pheochromocytomas are most often benign but may be associated with severe cardiovascular complications due to catecholamine excess. Their clinical diagnosis remains challenging due to the lack of specific signs and symptoms. The diagnosis relies on biochemical assays of catecholamine metabolites, supported by functional and anatomical imaging techniques. Surgical excision, preceded by meticulous pharmacologic preparation, remains the cornerstone of treatment. Early diagnosis and appropriate management are essential to prevent potentially life-threatening complications and ensure favorable outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.